{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:10:47Z","timestamp":1791259847816,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["K23 AR059763"],"award-info":[{"award-number":["K23 AR059763"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["L30 AR054311"],"award-info":[{"award-number":["L30 AR054311"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Esophageal dysfunction and gastro\u2010esophageal reflux disease (<jats:styled-content style=\"fixed-case\">GERD<\/jats:styled-content>) are common among patients with systemic sclerosis (<jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c). Although high\u2010dose proton pump inhibitors (<jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s) typically normalize esophageal acid exposure, the effectiveness of <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> therapy has not been systematically studied in <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c patients. The aim of this study was to characterize reflux in <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c patients on high\u2010dose <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> using esophageal pH\u2010impedance testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this case\u2010controlled retrospective analysis, 38 patients fulfilling 2013 American College of Rheumatology <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c criteria who underwent esophageal pH\u2010impedance testing on twice\u2010daily <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> between January 2014 and March 2017 at a tertiary referral center were compared with a control\u2010cohort of 38 non\u2010<jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c patients matched for <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> formulation and dose, hiatal hernia size, age, and gender. Patient clinical characteristics, including endoscopy and high\u2010resolution manometry findings, were assessed via chart review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p>On pH\u2010impedance, <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c patients had higher acid exposure times (<jats:styled-content style=\"fixed-case\">AET<\/jats:styled-content>s) than controls. Sixty\u2010one percent of the <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c patients and 18% of the control patients had a total <jats:styled-content style=\"fixed-case\">AET<\/jats:styled-content> \u22654.5% (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.001). Systemic sclerosis patients also had significantly longer <jats:styled-content style=\"fixed-case\">AET<\/jats:styled-content>s, longer median bolus clearance, and lower nocturnal impedance values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions &amp; Inferences<\/jats:title><jats:p>Abnormal esophageal acid exposure despite high\u2010dose <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> therapy was common among patients with <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c. The lack of increased reflux episodes in the <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>c patients, and longer bolus clearance times and lower nocturnal impedance, supports ineffective clearance as the potential mechanism. Systemic sclerosis patients may require adjunctive therapies to <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s to control acid reflux.<\/jats:p><\/jats:sec>","DOI":"10.1111\/nmo.13247","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T02:46:39Z","timestamp":1510022799000},"source":"Crossref","is-referenced-by-count":34,"title":["Abnormal esophageal acid exposure on high\u2010dose proton pump inhibitor therapy is common in systemic sclerosis patients"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0896-2522","authenticated-orcid":false,"given":"E. K.","family":"Stern","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-7758","authenticated-orcid":false,"given":"D. A.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Falmagne","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carns","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Pandolfino","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hinchcliff","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Brenner","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1595-y"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-014-0005-0"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200808-1359OC"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.03.002"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.03.025"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.04.007"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.08.034"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12813"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0475-y"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.08.002"},{"key":"e_1_2_9_12_1","first-page":"S\u2010214","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi N","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2016.44","article-title":"Therapy: risks associated with chronic PPI use \u2010 signal or noise?","volume":"13","author":"Kia L","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.031"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41210.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.012"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0576-5"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S24063"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198606001-00008"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.06.026"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04142.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12889"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909092245"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-015-0241-2"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.02.004"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew216"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.13247","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.13247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:06:19Z","timestamp":1695888379000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.13247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/nmo.13247"],"URL":"https:\/\/doi.org\/10.1111\/nmo.13247","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]},"article-number":"e13247"}}